Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The primary objectives of the study are to evaluate the safety and effect of KPI-121 0.25%
ophthalmic suspension and KPI-121 1.0% ophthalmic suspension on intraretinal or subretinal
fluid secondary to Retinal Vein Occlusion or Diabetic Macular Edema.